Home Cart 0 Sign in  
X

[ CAS No. 13473-01-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 13473-01-3
Chemical Structure| 13473-01-3
Chemical Structure| 13473-01-3
Structure of 13473-01-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 13473-01-3 ]

Related Doc. of [ 13473-01-3 ]

Alternatived Products of [ 13473-01-3 ]

Product Details of [ 13473-01-3 ]

CAS No. :13473-01-3 MDL No. :MFCD06254388
Formula : C6H6ClNO Boiling Point : -
Linear Structure Formula :- InChI Key :NPYYXUYLIHZYOU-UHFFFAOYSA-N
M.W : 143.57 Pubchem ID :4738276
Synonyms :

Calculated chemistry of [ 13473-01-3 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 35.74
TPSA : 22.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.51 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.07
Log Po/w (XLOGP3) : 2.35
Log Po/w (WLOGP) : 1.74
Log Po/w (MLOGP) : 1.16
Log Po/w (SILICOS-IT) : 2.0
Consensus Log Po/w : 1.86

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.64
Solubility : 0.33 mg/ml ; 0.0023 mol/l
Class : Soluble
Log S (Ali) : -2.45
Solubility : 0.504 mg/ml ; 0.00351 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.74
Solubility : 0.259 mg/ml ; 0.0018 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.59

Safety of [ 13473-01-3 ]

Signal Word:Danger Class:3,8
Precautionary Statements:P280-P305+P351+P338 UN#:2924
Hazard Statements:H225-H302-H318 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 13473-01-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 13473-01-3 ]
  • Downstream synthetic route of [ 13473-01-3 ]

[ 13473-01-3 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 13473-01-3 ]
  • [ 16110-09-1 ]
Reference: [1] Synthetic Communications, 1990, vol. 20, # 19, p. 2971 - 2977
  • 2
  • [ 2457-47-8 ]
  • [ 13473-01-3 ]
Reference: [1] Tetrahedron, 1985, vol. 41, # 7, p. 1373 - 1384
  • 3
  • [ 16110-09-1 ]
  • [ 67-56-1 ]
  • [ 13473-01-3 ]
YieldReaction ConditionsOperation in experiment
65% With sodium hydride In mineral oil a.
5-Chloro-2-methoxypyridine
Sodium hydride (60percent in mineral oil, 5.50 g, 115 mmol, 2 eq) was added portionwise to dry methanol (distilled from Mg, 25 mL) under a nitrogen atmosphere.
To this solution was added 2,5-dichloropyridine (10.0 g, 68 mmol).
After refluxing the resulting solution for 18 h, the reaction was cooled and treated with excess solid potassium bicarbonate.
The reaction was filtered and concentrated to 50percent of its original volume upon which the solution solidified.
The solids were washed with hexane and combined washes were concentrated to an oil.
The title compound was purified by reduced pressure distillation (102° C., 2400 pascal) to yield 6.30 g (65percent) of a colorless oil. MS (CI, CH4) m/z 144 (M+,100), 146 (44), 172 (M+28,19), 124 (9).
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1, 2000, # 8, p. 1245 - 1249
[2] Patent: US5512575, 1996, A,
  • 4
  • [ 13472-85-0 ]
  • [ 13473-01-3 ]
Reference: [1] Synthesis, 2012, vol. 44, # 5, p. 735 - 746
[2] Synlett, 2009, # 15, p. 2508 - 2512
  • 5
  • [ 16110-09-1 ]
  • [ 13473-01-3 ]
Reference: [1] Patent: US4588733, 1986, A,
  • 6
  • [ 16110-09-1 ]
  • [ 124-41-4 ]
  • [ 13473-01-3 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 1583 - 1592
  • 7
  • [ 1628-89-3 ]
  • [ 13473-01-3 ]
Reference: [1] Synthesis, 2012, vol. 44, # 5, p. 735 - 746
  • 8
  • [ 557-21-1 ]
  • [ 13473-01-3 ]
  • [ 15871-85-9 ]
YieldReaction ConditionsOperation in experiment
75% With dmap; 1,1'-bis-(diphenylphosphino)ferrocene; nickel(II) chloride hexahydrate; zinc In acetonitrile at 80℃; for 3 h; Inert atmosphere; Sealed tube General procedure: Under argon protection, NiCl2·6H2O (0.05mmo 1,11.9mg), dppf (0.06mmol, 33.3mg), Zn (0·2mmol, 13.0mg), DMAP (1.0mmol, 122.2mg), Zn(CN)2 (0.8mmol) , 93.9mg), p-Chloroanisole (1.0 mmol, 140.6 mg) and acetonitrile (5.0 mL) were sequentially added in a 25.0 mL sealed tube, then directly put it into the oil bath at 60 °C, and heating was stopped after 6h, and cooled to room temperature, the reaction solution was directly filtered through a short silica gel column, washed with dichloromethane, concentrated and purified by silica gel column chromatography( given that the product is most easily pulled out, in order to avoid loss of sample mix, unless otherwise noted, both are wet method). Eluent: petroleum ether / ethyl acetate = 20:1, the product was 117.2 mg as a white solid, yield 88percent, and 1H NMR purity was greater than 98percent.
Reference: [1] Organic Letters, 2017, vol. 19, # 8, p. 2118 - 2121
[2] Patent: CN108623495, 2018, A, . Location in patent: Paragraph 0043; 0045; 0178-0180
  • 9
  • [ 13473-01-3 ]
  • [ 557-21-1 ]
  • [ 15871-85-9 ]
Reference: [1] Organic Letters, 2007, vol. 9, # 9, p. 1711 - 1714
  • 10
  • [ 13473-01-3 ]
  • [ 75-86-5 ]
  • [ 15871-85-9 ]
Reference: [1] Organic Process Research and Development, 2016, vol. 20, # 8, p. 1540 - 1545
  • 11
  • [ 13473-01-3 ]
  • [ 262295-96-5 ]
Reference: [1] Organic Letters, 2012, vol. 14, # 11, p. 2818 - 2821
  • 12
  • [ 13473-01-3 ]
  • [ 74115-12-1 ]
  • [ 98627-13-5 ]
Reference: [1] Tetrahedron, 1985, vol. 41, # 7, p. 1373 - 1384
  • 13
  • [ 13473-01-3 ]
  • [ 102830-75-1 ]
YieldReaction ConditionsOperation in experiment
64% at 80℃; for 6 h; PREPARATION 13; (5-Chloro-2-methoxypyridin-3-yl)boronic acid a) 3-Bromo-5-chloro-2-methoxypyridineA solution of bromine (1.5 mL, 29.28 mmol) in glacial acetic acid (7 mL) was slowly added to a mixture of 5-chloro-2-methoxypyridine (2.1 g, 14.63 mmol) and sodium acetate (1.2 g, 14.63 mmol) in glacial acetic acid (7 mL) and the resulting mixture was stirred at 80 °C for 6 hours. The reaction was allowed to cool down to ambient temperature and then diethyl ether and water were added. The organic layer was separated, washed with a 1N aqueous solution of sodium hydroxide and a 4percent aqueous solution of sodium bisulphite, dried over magnesium sulphate and the solvent removed under reduced pressure. The residue was purified by flash chromatography (100percent hexanes) to give the title compound (2.1 g, 64percent) as a white solid.1H-NMR δ (300 MHz, CDCI3): 3.99 (s, 3H), 7.81 (d, 1H), 8.05 (d, 1H).
64%
Stage #1: at 80℃; for 6 h;
Stage #2: With sodium hydroxide In diethyl ether; water
PREPARATION 13; (5-Chloro-2-methoxypyridin-3-yl)boronic acid a) 3-Bromo-5-chloro-2-methoxypyridine A solution of bromine (1.5 mL, 29.28 mmol) in glacial acetic acid (7 mL) was slowly added to a mixture of 5-chloro-2-methoxypyridine (2.1 g, 14.63 mmol) and sodium acetate (1.2 g, 14.63 mmol) in glacial acetic acid (7 mL) and the resulting mixture was stirred at 80 C for 6 hours. The reaction was allowed to cool down to room temperature and then diethyl ether and water were added. The organic layer was separated, washed with a 1 N aqueous solution of sodium hydroxide and a 4percent aqueous solution of sodium bisulphite, dried over magnesium sulphate and the solvent removed under reduced pressure. The residue was purified by flash chromatography (100percent hexanes) to give the title compound (2.1 g, 64percent) as a white solid. 1H-NMR δ (300 MHz, CDCl3): 3.99 (s, 3H), 7.81 (d, 1H), 8.05 (d, 1H).
Reference: [1] Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 1583 - 1592
[2] Journal of Medicinal Chemistry, 1986, vol. 29, # 9, p. 1590 - 1595
[3] Patent: WO2012/69202, 2012, A1, . Location in patent: Page/Page column 53
[4] Patent: EP2463289, 2012, A1, . Location in patent: Page/Page column 21
[5] Patent: US5512575, 1996, A,
[6] Patent: US4588733, 1986, A,
  • 14
  • [ 13473-01-3 ]
  • [ 5419-55-6 ]
  • [ 475275-69-5 ]
YieldReaction ConditionsOperation in experiment
10.44 g With lithium hexamethyldisilazane In tetrahydrofuran; n-heptane; ethylbenzene at -78 - 20℃; General procedure: General Method 1A: Preparation of a boronic acid At-78C, LDA (2 molar in THF/heptane/ethylbenzene) was added to a solution of theappropriate pyridine derivative in THF (3 ml/mmol), the mixture was stirred for2-4 h and triisopropyl borate was then added quickly. The reaction mixture wasmaintained at -78 C for a further 2-3 h and then slowly thawed to RT overnight.After addition of water, the THF was removed under reduced pressure and theaqueous phase was extracted twice with ethyl acetate The aqueous phase wasacidified with 2M hydrochloric acid, generally resulting in formation of aprecipitate which was filtered off, washed with water and dried. The aqueousphase was extracted three times with ethyl acetate. The combined organic phaseswere dried (sodium sulphate), filtered and concentrated under reduced pressure.10.0 g (69.65 mmol) of 5-chloro-2-methoxypyridine werereacted according to General Method 1A.The desired product precipitated on acidification with hydrochloric acid (2N).Yield: 10.44 g (purity 91percent, 73percent of theory)
16 g
Stage #1: With n-butyllithium In tetrahydrofuran at -30℃; for 0.5 h; Inert atmosphere
Stage #2: With 1,4,7,10-tetramethyl-1,4, 7,10-tetraazacyclododecane In tetrahydrofuran at -30 - 20℃; for 4 h;
Stage #3: With hydrogenchloride In tetrahydrofuran; water for 1 h;
Under a nitrogen atmosphere, 300 g of anhydrous tetrahydrofuran was added to the reaction flask, stirring was continued, 17 g of 5-chloro-2-methoxypyridine was added and cooled to -30C.A solution of 70 mL of 2.0 M of n-BuLi was slowly added dropwise, and after stirring for 30 minutes, 1,3 g of 1,4,7,10-tetramethyl-1,4,7,10-tetraazacyclododecane was slowly added dropwise.After 2 hours of incubation, 41 mL of triisopropyl borate was slowly added dropwise at -30 ° C, stirred for 1 hr, slowly raised to room temperature and stirred for 1 hour.And 400 g of concentrated hydrochloric acid was added thereto, followed by stirring for 1 hour to carry out a hydrolysis reaction.The layers were allowed to stand, and the organic layer was washed three times with water (3 x 100 g).The aqueous layers were combined and the aqueous layer was extracted once with 100 ml of petroleum ether. The combined organic layers were dried over 50 g of anhydrous sodium sulfate and filtered.The filtrate was concentrated to dryness to give 6-chloro-2-methoxy-4-pyridine boronic acid 16 g,
Reference: [1] Patent: KR2015/137095, 2015, A, . Location in patent: Paragraph 0706; 0707; 1293-1296
[2] Patent: US2016/272637, 2016, A1, . Location in patent: Paragraph 0673; 0674; 0675; 0676
[3] Patent: CN102718785, 2016, B, . Location in patent: Paragraph 0036; 0037
  • 15
  • [ 13473-01-3 ]
  • [ 475275-69-5 ]
Reference: [1] Journal of Organic Chemistry, 2002, vol. 67, # 21, p. 7541 - 7543
[2] Patent: US2016/52884, 2016, A1, . Location in patent: Paragraph 0548; 0925-0928
  • 16
  • [ 13473-01-3 ]
  • [ 121-43-7 ]
  • [ 475275-69-5 ]
YieldReaction ConditionsOperation in experiment
16 g
Stage #1: With n-butyllithium In tetrahydrofuran at -30℃; for 0.5 h; Inert atmosphere
Stage #2: With N,N',N''-trimethyl-1,4,7-triazacyclononane In tetrahydrofuran at -30 - 20℃; for 4 h;
Stage #3: With hydrogenchloride In tetrahydrofuran; water for 1 h;
Under a nitrogen atmosphere, 300 g of anhydrous tetrahydrofuran was added to the reaction flask, stirring was continued, 17 g of 5-chloro-2-methoxypyridine was added and cooled to -30C.Sulfur was added dropwise to 70 mL of 2.0 M of n-BuLi. After stirring for 30 minutes, 26 g of 1,4,7-trimethyl-1,4,7-triazacyclononane was slowly added dropwise.After incubation for 2 hours, 26 mL of trimethyl borate was slowly added dropwise at -30 ° C, stirred for 1 hr, slowly rose to room temperature and stirred for 1 hour.And 400 g of concentrated hydrochloric acid was added thereto, followed by stirring for 1 hour to carry out a hydrolysis reaction.The layers were allowed to stand, and the organic layer was washed three times with water (3 x 100 g).The aqueous layers were combined and the aqueous layer was extracted once with 100 ml of petroleum ether. The combined organic layers were dried over 50 g of anhydrous sodium sulfate and filtered.The filtrate was concentrated to dryness to give 16 g of product 5-chloro-2-methoxy-4-pyridine boronic acid.
Reference: [1] Patent: CN102718785, 2016, B, . Location in patent: Paragraph 0038; 0039
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 13473-01-3 ]

Chlorides

Chemical Structure| 1214323-40-6

[ 1214323-40-6 ]

5-Chloro-2-(difluoromethoxy)pyridine

Similarity: 0.86

Chemical Structure| 72141-44-7

[ 72141-44-7 ]

4-Chloro-2-methoxypyridine

Similarity: 0.83

Chemical Structure| 13472-58-7

[ 13472-58-7 ]

3,5-Dichloro-2-methoxypyridine

Similarity: 0.82

Chemical Structure| 58498-61-6

[ 58498-61-6 ]

5-Chloro-3-methylpyridin-2-ol

Similarity: 0.81

Chemical Structure| 1211534-25-6

[ 1211534-25-6 ]

4-Bromo-5-chloro-2-methoxypyridine

Similarity: 0.80

Ethers

Chemical Structure| 1214323-40-6

[ 1214323-40-6 ]

5-Chloro-2-(difluoromethoxy)pyridine

Similarity: 0.86

Chemical Structure| 72141-44-7

[ 72141-44-7 ]

4-Chloro-2-methoxypyridine

Similarity: 0.83

Chemical Structure| 13472-58-7

[ 13472-58-7 ]

3,5-Dichloro-2-methoxypyridine

Similarity: 0.82

Chemical Structure| 1211534-25-6

[ 1211534-25-6 ]

4-Bromo-5-chloro-2-methoxypyridine

Similarity: 0.80

Chemical Structure| 1628-89-3

[ 1628-89-3 ]

2-Methoxypyridine

Similarity: 0.80

Related Parent Nucleus of
[ 13473-01-3 ]

Pyridines

Chemical Structure| 1214323-40-6

[ 1214323-40-6 ]

5-Chloro-2-(difluoromethoxy)pyridine

Similarity: 0.86

Chemical Structure| 72141-44-7

[ 72141-44-7 ]

4-Chloro-2-methoxypyridine

Similarity: 0.83

Chemical Structure| 13472-58-7

[ 13472-58-7 ]

3,5-Dichloro-2-methoxypyridine

Similarity: 0.82

Chemical Structure| 58498-61-6

[ 58498-61-6 ]

5-Chloro-3-methylpyridin-2-ol

Similarity: 0.81

Chemical Structure| 1211534-25-6

[ 1211534-25-6 ]

4-Bromo-5-chloro-2-methoxypyridine

Similarity: 0.80